US FDA’s Trump Transition Relatively Smooth, Except For Diversity, Equity Work

headshots of diverse people pasted side by side
The FDA's efforts to better understand medical product safety and efficacy in different populations could be at risk during the Trump Administration. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Diversity & Inclusion

More from R&D